— Know what they know.
Not Investment Advice

HYPR NASDAQ

Hyperfine, Inc.
1W: +9.9% 1M: +10.9% 3M: -29.6% YTD: -7.8% 1Y: -37.1% 3Y: -56.0% 5Y: -91.0%
$0.89
+0.02 (+2.54%)
 
Weekly Expected Move ±6.2%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 60 · $75.3M mcap · 67M float · 1.25% daily turnover · Short 66% of daily vol
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$75.3M
52W Range0.7536-2.22
Volume1,403,775
Avg Volume831,124
Beta1.41
Dividend—
Analyst Ratings
4 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOMaria Degois Sainz
Employees102
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-01-28
351 New Whitfield Street
Guilford, CT 06437
US
203-458-7100
About Hyperfine, Inc.

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Recent Insider Trades

NameTypeSharesPriceDate
TEISSEYRE THOMAS S-Sale 7,345 $0.85 2026-08-24
HALE BRETT S-Sale 7,345 $0.85 2026-08-24
Wolterman Dan A-Award 52,600 $1.49 2026-06-03
HALE BRETT S-Sale 6,047 $1.65 2026-05-26
TEISSEYRE THOMAS S-Sale 6,047 $1.65 2026-05-26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms